Home › Idiopathic Pulmonary Fibrosis › Alabama › Birmingham
Idiopathic Pulmonary Fibrosis clinical trials in Birmingham, AL
9 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Birmingham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
RecruitingPhase 2
- Research Site, Birmingham
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- UAB, Psychiatry and Behavioral Neurology, Birmingham
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- UAB Lung Health Center, Birmingham
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- The University of Alabama at Birmingham /ID# 277613, Birmingham
Molecular Imaging Probes to Inform Heterogeneity in Idiopathic Pulmonary Fibrosis
RecruitingPhase 1
- The University of Alabama at Birmingham, Birmingham
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
RecruitingObservational study
- University of Alabama - Birmingham, Birmingham
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 2
- WISPer Site in Birmingham, AL, Birmingham
Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of Alabama at Birmingham, Birmingham
Idiopathic Pulmonary Fibrosis trials in other cities
- New York City, NY8 studies
- Kansas City, KS7 studies
- Philadelphia, PA7 studies
- Los Angeles, CA7 studies
- Chicago, IL6 studies
- Aurora, CO6 studies
- Durham, NC6 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Charleston, SC5 studies
- Houston, TX5 studies
- Atlanta, GA5 studies
Other studies in Birmingham
- Cancer (all types)31 studies
- Breast Cancer24 studies
- Ovarian Cancer23 studies
- Obesity23 studies
- Non-Small Cell Lung Cancer22 studies
- Acute Myeloid Leukemia21 studies
- Multiple Myeloma18 studies
- COPD17 studies
- Cardiovascular Disease17 studies
- Type 2 Diabetes16 studies
- Endometrial Cancer16 studies
- Overweight16 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.